- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A Cipralex letter omitted key details from a PCT newsletter about non-formulary status and infrequent specialist use, implying broader acceptance. PMCPA found…
A consumer press release for Efient (prasugrel) claimed “up to 25%” of patients don’t respond adequately to clopidogrel. PMCPA found the statement…
A “marketing study” survey on botulinum toxins sent to 800+ neurologists was ruled promotional, disguised as research, and inconsistent with Botox SPC.…
Novo Nordisk’s Victoza launch activity led to multiple Code breaches, mainly around misleading claims, lack of balance/safety info, and public-facing materials. Appeal…
Anonymous alleged an AstraZeneca meeting misled HCPs and promoted Seroquel (quetiapine) for borderline personality disorder. Panel found no evidence of off-label promotion…
A GP said a Movicol mailing misrepresented NICE constipation guidance. PMCPA ruled it misled by implying NICE specifically recommended Movicol for 12+;…
A Nicorette presentation slide claimed “no statistically significant difference” vs varenicline, but the study wasn’t powered for that comparison. A footnote didn’t…
HCP complained Richter Resource Centre was disguised promotion and accessible to the public. Panel found no disguised promotion/public advertising, but ruled breaches…
Anonymous employee alleged Astellas misled PMCPA about Milan advisory board delegate selection. Panel/Appeal Board found false/incomplete information and dismissive senior messaging. Result:…
AstraZeneca’s global Twitter account re-tweeted a US disease-awareness post linking to HFSA events. Complaint alleged multiple Code breaches, but the Panel found…
Corporate product pages naming POMs and indications were accessible to the public without clear audience separation or public reference info. PMCPA ruled…
Health professional said Jinarc training site was promotional, lacked clear PI and implied MHRA endorsement. Panel found it was MHRA-mandated risk-minimisation training…
GSK Consumer Healthcare’s NiQuitin 21mg Clear Patch leavepiece compared nicotine delivery vs rival patches. Panel found it could imply clinical superiority without…
Intercompany complaint about Jext leavepiece diagrams and the claim “designed to be easy to use”. Panel found the diagrams aligned with the…
Anonymous complaint alleged reps used litmus paper and eye drops to demonstrate pH and encouraged instillation into eyes. Panel found no evidence…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.